A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT

被引：0
|
作者：
Armin D Goralczyk
Andreas Schnitzbauer
Tung Y Tsui
Giuliano Ramadori
Thomas Lorf
Aiman Obed
机构：
[1] University Medical Center Göttingen,Department of General and Visceral Surgery
[2] Universitätsklinikum Regensburg,Klinik und Poliklinik für Chirurgie
[3] Universitätsklinikum Hamburg-Eppendorf,Department of Hepatobiliary and Transplant Surgery
[4] University Medical Center Göttingen,Department of Gastroenterology and Endocrinology
来源：
BMC Surgery | / 10卷
关键词：
Everolimus; Acute Rejection; Orthotopic Liver Transplantation; Immunosuppressive Regimen; Daclizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION
    Guba, M.
    Pratschke, J.
    Pressmar, K.
    Kraemer, B.
    Andrassy, J.
    Reinke, P.
    Hugo, C.
    Hakenberg, O.
    Fischereder, M.
    Pascher, A.
    Stangl, M.
    Banas, B.
    Jauch, K. -W.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 60 - 60
  • [22] EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION
    Guba, M.
    Pratschke, J.
    Hugo, C.
    Kraemer, B.
    Pascher, A.
    Pressmar, K.
    Hakenberg, O.
    Fischereder, M.
    Brockmann, J.
    Andrassy, J.
    Stangl, M.
    Banas, B.
    Jauch, K. -W.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 21 - 22
  • [23] Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation
    Guba, Markus
    Pratschke, Johann
    Hugo, Christian
    Kraemer, Bernhard K.
    Pascher, Andreas
    Pressmar, Katharina
    Hakenberg, Oliver
    Fischereder, Michael
    Brockmann, Jens
    Andrassy, Joachim
    Banas, Bernhard
    Jauch, Karl-Walter
    TRANSPLANT INTERNATIONAL, 2012, 25 (04) : 416 - 423
  • [24] EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION
    Guba, Markus
    Pratschke, Johann
    Hugo, Christian
    Kraemer, Bernhard K.
    Pascher, Andreas
    Pressmar, Katharina
    Hakenberg, Oliver
    Fischereder, Michael
    Brockmann, Jens
    Andrassy, Joachim
    Stangl, Manfred
    Bernhard, Banas
    Jauch, Karl-Walter
    TRANSPLANT INTERNATIONAL, 2011, 24 : 250 - 250
  • [25] Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment: Results of a Pilot Study (PATRON07)
    Schnitzbauer, Andreas A.
    Sothmann, Johannes
    Baier, Lucia
    Bein, Thomas
    Geissler, Edward K.
    Scherer, Marcus N.
    Schlitt, Hans J.
    TRANSPLANTATION, 2015, 99 (12) : 2565 - 2575
  • [26] RENAL IMPAIRMENT AFTER LIVER TRANSPLANTATION - A PILOT TRIAL OF CALCINEURIN INHIBITOR-FREE VS. CALCINEURIN INHIBITOR SPARING IMMUNOSUPPRESSION IN PATIENTS WITH MILDLY IMPAIRED RENAL FUNCTION AFTER LIVER TRANSPLANTATION
    Gerhardt, T.
    Terjung, B.
    Knipper, P.
    Palmedo, H.
    Woitas, R. P.
    Kalff, J.
    Sauerbruch, T.
    Spengler, U.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (05) : 210 - 215
  • [27] Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation
    T Gerhardt
    B Terjung
    P Knipper
    H Palmedo
    RP Woitas
    J Kalff
    T Sauerbruch
    U Spengler
    European Journal of Medical Research, 14
  • [28] Impact of calcineurin inhibitor-free immunosuppression on de novo donor-specific antibody formation in liver transplant recipients
    Meszaros, Magdalena
    Dubois, Valerie
    Congy-Jolivet, Nicolas
    Hamada, Sarah
    Thevenin, Celine
    Faure, Stephanie
    Boillot, Olivier
    Kamar, Nassim
    Pageaux, Georges-Philippe
    Del Bello, Arnaud
    Dumortier, Jerome
    LIVER INTERNATIONAL, 2022, 42 (05) : 1132 - 1143
  • [29] Calcineurin-inhibitor-free immunosuppression with mycophenolate mofetil and sirolimus after cardiac transplantation is safe and improves renal function significantly: 1 year follow up.
    Groetzner, J
    Kaczmarek, I
    Mueller, M
    Adamidis, J
    Vogeser, M
    Ueberfuhr, P
    Daebritz, S
    Meiser, B
    Reichart, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 281 - 281
  • [30] Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial (vol 377, pg 837, 2011)
    Budde, K.
    Becker, T.
    Arns, W.
    LANCET, 2011, 377 (9782): : 2006 - 2006
12345